One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Deciphering the Differences Between Stricturing With or Without Penetrating Crohn’s Disease: One Step Closer to Solving the Puzzle Free
doi : 10.1093/ecco-jcc/jjae099
Volume 18, Issue 11, November 2024
Fibrosis-related Transcriptome Unveils a Distinctive Remodelling Matrix Pattern in Penetrating Ileal Crohn’s Disease Free
doi : 10.1093/ecco-jcc/jjae064
The Effect of Non-pooled Multidonor Faecal Microbiota Transplantation for Inducing Clinical Remission in Patients with Chronic Pouchitis: Results from a Multicentre, Randomised, Double-blinded, Placebo-controlled Trial [MicroPouch] Free
doi : 10.1093/ecco-jcc/jjae066
Associations Between Brain Morphology, Inflammatory Markers, and Symptoms of Fatigue, Depression, or Anxiety in Active and Remitted Crohn’s Disease
doi : 10.1093/ecco-jcc/jjae078
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials Open Access
doi : 10.1093/ecco-jcc/jjae079
Seeing Beyond the Surface: Superior Performance of Ultrasound Elastography over Milan Ultrasound Criteria in Distinguishing Fibrosis of Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjae081
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease Open Access
doi : 10.1093/ecco-jcc/jjae083
Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy Open Access
doi : 10.1093/ecco-jcc/jjae084
Serum Metabolites Relate to Mucosal and Transmural Inflammation in Paediatric Crohn Disease Open Access
doi : 10.1093/ecco-jcc/jjae085
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme Open Access
doi : 10.1093/ecco-jcc/jjae088
Perioperative Enhanced Recovery Concepts Significantly Improve Postoperative Outcome in Patients with Crohn`s Disease
doi : 10.1093/ecco-jcc/jjae090
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis Open Access
doi : 10.1093/ecco-jcc/jjae092
Intravenous Albumin Infusion Does not Augment the Response Rate to a Combination of Exclusive Enteral Nutrition and Intravenous Steroids in Acute Severe Ulcerative Colitis: A Randomised Controlled Trial
doi : 10.1093/ecco-jcc/jjae094
Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial]
doi : 10.1093/ecco-jcc/jjae095
Serum Extracellular Matrix Molecules and Their Fragments as Biomarkers of Inflammation and Fibrosis in Inflammatory Bowel Diseases: A Systematic Review
doi : 10.1093/ecco-jcc/jjae077
Corrigendum to: Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials Open Access
doi : 10.1093/ecco-jcc/jjae156
